SCHEMBL28983491

SCHEMBL28983491

COC(=O)COC(=O)c1cc(OC2CCN(C(=O)OC(C)(C)C)CC2)c(F)cc1[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 6/20 0.47
▸ PDE4D Q08499 3/20 0.42
▸ PDE4B Q07343 3/20 0.42
▸ PDE4A P27815 2/20 0.42
▸ PDE4C Q08493 2/20 0.42
▸ SCN9A Q15858 2/20 0.41
▸ MAPT P10636 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ GPR174 Q9BXC1 3/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ DPP4 P27487 1/20 0.37
▸ PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21612831 0.90 GPR119 (0.52) GPR119PDE4DPDE4BPDE4APDE4C
SCHEMBL29685176 0.90 PDE4D (0.41) GPR119PDE4DPDE4BPDE4APDE4C
SCHEMBL29205709 0.90 GPR119 (0.52) GPR119PDE4DPDE4BPDE4APDE4C
SCHEMBL21612824 0.85 GPR119 (0.54) GPR119PDE4DPDE4BPDE4APDE4C
SCHEMBL29686047 0.85 GPR119 (0.54) GPR119PDE4DPDE4BPDE4APDE4C
SCHEMBL28983515 0.81 LMNA (0.38) MAPTMEN1KMT2ALMNACYP1A2
SCHEMBL21612843 0.80 PDE4B (0.45) GPR119PDE4DPDE4BPDE4APDE4C
SCHEMBL21612772 0.80 PDE4B (0.44) GPR119PDE4DPDE4BPDE4APDE4C
SCHEMBL28983492 0.79 LMNA (0.40) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL21612833 0.79 PDE4D (0.47) GPR119PDE4DPDE4BPDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115803326-A EGFR inhibitor, preparation method and pharmaceutical application thereof 上海和誉生物医药科技有限公司 2023-03-14 — — CN disclosed
WO-2022105908-A1 EGFR INHIBITOR, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF 上海和誉生物医药科技有限公司 2022-05-27 — — WO disclosed
Send feedback